229 related articles for article (PubMed ID: 32860777)
1. Differential glutamatergic and GABAergic contributions to the tetrad effects of Δ
De Giacomo V; Ruehle S; Lutz B; Häring M; Remmers F
Neuropharmacology; 2020 Nov; 179():108287. PubMed ID: 32860777
[TBL] [Abstract][Full Text] [Related]
2. Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice.
Monory K; Blaudzun H; Massa F; Kaiser N; Lemberger T; Schütz G; Wotjak CT; Lutz B; Marsicano G
PLoS Biol; 2007 Oct; 5(10):e269. PubMed ID: 17927447
[TBL] [Abstract][Full Text] [Related]
3. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB
Wang XF; Galaj E; Bi GH; Zhang C; He Y; Zhan J; Bauman MH; Gardner EL; Xi ZX
Br J Pharmacol; 2020 Apr; 177(8):1865-1880. PubMed ID: 31877572
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid-Induced Tetrad in Mice.
Metna-Laurent M; Mondésir M; Grel A; Vallée M; Piazza PV
Curr Protoc Neurosci; 2017 Jul; 80():9.59.1-9.59.10. PubMed ID: 28678398
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018.
Gamage TF; Barrus DG; Kevin RC; Finlay DB; Lefever TW; Patel PR; Grabenauer MA; Glass M; McGregor IS; Wiley JL; Thomas BF
Pharmacol Biochem Behav; 2020 Jun; 193():172918. PubMed ID: 32247816
[TBL] [Abstract][Full Text] [Related]
6. Receptor mechanisms underlying the CNS effects of cannabinoids: CB
Hempel B; Xi ZX
Adv Pharmacol; 2022; 93():275-333. PubMed ID: 35341569
[TBL] [Abstract][Full Text] [Related]
7. Sex, species and age: Effects of rodent demographics on the pharmacology of ∆
Wiley JL; Barrus DG; Farquhar CE; Lefever TW; Gamage TF
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110064. PubMed ID: 32810571
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of the pharmacological effects of THC by mTOR blockade.
Puighermanal E; Busquets-Garcia A; Gomis-González M; Marsicano G; Maldonado R; Ozaita A
Neuropsychopharmacology; 2013 Jun; 38(7):1334-43. PubMed ID: 23358238
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
DeLong GT; Wolf CE; Poklis A; Lichtman AH
Drug Alcohol Depend; 2010 Nov; 112(1-2):126-33. PubMed ID: 20619971
[TBL] [Abstract][Full Text] [Related]
10. CB
Trexler KR; Eckard ML; Kinsey SG
Pharmacol Biochem Behav; 2019 Feb; 177():27-33. PubMed ID: 30597181
[TBL] [Abstract][Full Text] [Related]
11. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ
Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid CB₁ receptor in the modulation of stress coping behavior in mice: the role of serotonin and different forebrain neuronal subpopulations.
Häring M; Grieb M; Monory K; Lutz B; Moreira FA
Neuropharmacology; 2013 Feb; 65():83-9. PubMed ID: 23000076
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions.
Ruehle S; Remmers F; Romo-Parra H; Massa F; Wickert M; Wörtge S; Häring M; Kaiser N; Marsicano G; Pape HC; Lutz B
J Neurosci; 2013 Jun; 33(25):10264-77. PubMed ID: 23785142
[TBL] [Abstract][Full Text] [Related]
14. Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons.
de Salas-Quiroga A; Díaz-Alonso J; García-Rincón D; Remmers F; Vega D; Gómez-Cañas M; Lutz B; Guzmán M; Galve-Roperh I
Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13693-8. PubMed ID: 26460022
[TBL] [Abstract][Full Text] [Related]
15. CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ
Han X; He Y; Bi GH; Zhang HY; Song R; Liu QR; Egan JM; Gardner EL; Li J; Xi ZX
Sci Rep; 2017 Sep; 7(1):12315. PubMed ID: 28951549
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice.
Han X; Liang Y; Hempel B; Jordan CJ; Shen H; Bi GH; Li J; Xi ZX
J Neurosci; 2023 Jan; 43(3):373-385. PubMed ID: 36517243
[TBL] [Abstract][Full Text] [Related]
17. Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.
Canazza I; Ossato A; Trapella C; Fantinati A; De Luca MA; Margiani G; Vincenzi F; Rimondo C; Di Rosa F; Gregori A; Varani K; Borea PA; Serpelloni G; Marti M
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3685-3709. PubMed ID: 27527584
[TBL] [Abstract][Full Text] [Related]
18. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
Laaris N; Good CH; Lupica CR
Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
[TBL] [Abstract][Full Text] [Related]
19. Cell type-specific genetic reconstitution of CB1 receptor subsets to assess their role in exploratory behaviour, sociability, and memory.
De Giacomo V; Ruehle S; Lutz B; Häring M; Remmers F
Eur J Neurosci; 2022 Feb; 55(4):939-951. PubMed ID: 33253450
[TBL] [Abstract][Full Text] [Related]
20. CB1-Dependent Long-Term Depression in Ventral Tegmental Area GABA Neurons: A Novel Target for Marijuana.
Friend L; Weed J; Sandoval P; Nufer T; Ostlund I; Edwards JG
J Neurosci; 2017 Nov; 37(45):10943-10954. PubMed ID: 29038246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
